Arrhythmogenic Implications of Inflammatory Bowel Disease: Its Mechanisms and Treatment Effects

Area of Science:

• Gastroenterology and Cardiology
• Systemic Inflammatory Diseases
• Cardiovascular Medicine

Background:

• Inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis, is increasingly viewed as a systemic condition.
• Emerging evidence highlights a significant association between IBD and cardiovascular complications, especially cardiac arrhythmias.
• Persistent inflammation and certain medications are implicated as key drivers of this association.

Purpose of the Study:

• To review current clinical and mechanistic insights into the relationship between IBD and the risk of developing cardiac arrhythmias.
• To integrate findings from recent epidemiological and genetic studies.

Main Methods:

• Literature review integrating clinical and mechanistic data.
• Analysis of epidemiological and genetic studies.
• Examination of drug effects on cardiovascular health in IBD patients.

Main Results:

• Patients with IBD exhibit a higher incidence of atrial fibrillation, atrioventricular block, and conduction abnormalities, independent of traditional cardiovascular risk factors.
• Systemic cytokine activation, autonomic dysfunction, and cardiac remodeling are identified as central mediators.
• Aminosalicylates may cause myocarditis; corticosteroids have dose/duration-dependent effects; biologic agents generally show cardiac safety.

Conclusions:

• The link between IBD and arrhythmias underscores the need for thorough cardiovascular evaluation in IBD patients.
• Effective inflammation control is vital for mitigating cardiac risks.
• Multidisciplinary management and further research are essential for improved risk prediction and cardiac outcomes.